Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.

[1]  C. Giachelli,et al.  A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.

[2]  Su‐Li Cheng,et al.  Targeted Reduction of Vascular Msx1 and Msx2 Mitigates Arteriosclerotic Calcification and Aortic Stiffness in LDLR-Deficient Mice Fed Diabetogenic Diets , 2014, Diabetes.

[3]  S. Mu,et al.  Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. , 2014, Kidney international.

[4]  M. Rosenfeld,et al.  Bone Marrow– or Vessel Wall–Derived Osteoprotegerin Is Sufficient to Reduce Atherosclerotic Lesion Size and Vascular Calcification , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[5]  H. Qiu,et al.  Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway , 2013, PloS one.

[6]  Kazuyoshi Uchihashi,et al.  FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. , 2013, Contributions to nephrology.

[7]  Elena Aikawa,et al.  Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.

[8]  M. Budoff,et al.  Fibroblast growth factor 23 is not associated with and does not induce arterial calcification , 2013, Kidney international.

[9]  Yong Sun,et al.  Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification , 2012, Circulation research.

[10]  L. Hsiao,et al.  Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23 , 2012, Circulation.

[11]  Xianwu Li,et al.  Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis , 2010, Journal of cellular biochemistry.

[12]  C. Chazot,et al.  High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  M. Kurabayashi,et al.  Notch Signaling Induces Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells: Role of Msx2 Gene Induction via Notch-RBP-Jk Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[14]  B. Coll,et al.  RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway , 2009, Circulation research.

[15]  T. Callister,et al.  SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. , 2009, Journal of cardiovascular computed tomography.

[16]  M. Tamura,et al.  Bone morphogenetic protein‐2 enhances Wnt/β‐catenin signaling‐induced osteoprotegerin expression , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[17]  M. Wolf,et al.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. , 2008, The New England journal of medicine.

[18]  D. Brancaccio,et al.  Vascular Calcification and Uremia: What Do We Know? , 2007, American Journal of Nephrology.

[19]  Hiroki Matsui,et al.  Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells , 2007, Molecular and Cellular Biology.

[20]  K. Boström,et al.  Regulation of Bone Morphogenetic Protein-4 by Matrix GLA Protein in Vascular Endothelial Cells Involves Activin-like Kinase Receptor 1* , 2006, Journal of Biological Chemistry.

[21]  Hiroki Matsui,et al.  Jagged1-selective Notch Signaling Induces Smooth Muscle Differentiation via a RBP-Jκ-dependent Pathway* , 2006, Journal of Biological Chemistry.

[22]  Brian J. Bennett,et al.  Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R. Quigley,et al.  Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. , 2005, Kidney international.

[24]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  P. Weissberg,et al.  Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[26]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[27]  S. Morony,et al.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.

[28]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[29]  J. Skepper,et al.  Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[30]  P L Weissberg,et al.  Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. , 1993, Circulation research.

[31]  K. Watson,et al.  Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[32]  S. Abbara ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography , 2011 .

[33]  大窄マリアナ今日美 Estrogen inhibits vascular calcification via vascular RANKL system : common mechanism of osteoporosis and vascular calcification , 2010 .

[34]  清水 岳久 Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells : role of Msx2 gene induction via Notch-RBP-Jk signaling , 2009 .

[35]  G. Owens,et al.  Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. , 2007, American journal of physiology. Cell physiology.